BSX vs DMRC · P/E 20, rev $10.65B vs rev $38.4M
Boston Scientific Corp (BSX) versus Digimarc Corporation (DMRC) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Digimarc Corporation (DMRC) is a software - application company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported DMRC revenue for 2024-12-31 was $38.4M. Net income was -$39.0M. Revenue was up 10.2% from 2023-12-31 to 2024-12-31. DMRC currently screens at market cap $327.0M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. DMRC currently screens at market cap $327.0M.
Not investment advice. Open the BSX and DMRC stock pages for the full models.
Not investment advice.